recombinant human GH
24 obese subjects        (22 women and 2 men; 22-46 years old) were fed a diet of 25 kcal/kg ideal body       weight (IBW) with 1.2 g protein/kg IBW daily and were treated with recombinant       human GH (n = 12, 0.18 U/kg IBW/week) or placebo (n = 12, vehicle injection) in a       12-week randomized, double-blind and placebo-controlled trial.
24  @OBJECT$  subjects        (22 women and 2 men; 22-46 years old) were fed a diet of 25 kcal/kg ideal body       weight (IBW) with 1.2 g protein/kg IBW daily and were  @PREDICAT$  with  @SUBJECT$  (n = 12, 0.18 U/kg IBW/week) or placebo (n = 12, vehicle injection) in a       12-week randomized, double-blind and placebo-controlled trial.